Evidence map›Paper›PMID 42384743›Full record

ReviewBioconjugate chemistry2026

Artificial Intelligence for Discovery in Life Sciences.

Sushovan Chanda, Silvio O Rizzoli, Ali H Shaib

Abstract readReview
In one paragraph

Review in Bioconjugate chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sushovan ChandaDepartment of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen 37073, Germany.
Silvio O RizzoliDepartment of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen 37073, Germany.ORCID 0000-0002-1667-7839
Ali H ShaibDepartment of Neuro- and Sensory Physiology, University Medical Center Göttingen, Göttingen 37073, Germany.ORCID 0009-0007-2656-3820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence is becoming a transformative tool in life sciences, not just by improving the results of existing technologies but also by introducing fundamental new ways of discovery. Initially applied to denoising, segmentation, or pattern recognition, it now extends across microscopy, structural biology, protein engineering, experimental design, and hypothesis generation. In imaging, deep learning enhances fluorescence, cryo-EM, and expansion microscopy and increasingly links optical and non-optical modalities. Beyond imaging, AI accelerates fluorescent probe development, while large language models and multi-agent systems are beginning to synthesize literature, generate hypotheses, and guide experiments. We survey these developments across imaging and non-imaging domains, from microscopy and structural biology to molecular design, hypothesis generation, and autonomous experimentation. We discuss the convergence of AI with tools from chemistry to instrumentation and explain challenges in validation, interpretability, generalizability, and autonomy. We conclude that AI is beginning to connect measurement, design, and reasoning to accelerate biological discovery.

Indexed as

Artificial IntelligenceBiological Science DisciplinesAnimalsHumansLarge Language Models

Identifiers

PMID42384743
PMCPMC13377596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.